Hypoxia-microRNA-16 downregulation induces VEGF expression in anaplastic lymphoma kinase (ALK)-positive anaplastic large-cell lymphomas.

Autor: Dejean, E, Renalier, M H, Foisseau, M, Agirre, X, Joseph, N, de Paiva, G R, Al Saati, T, Soulier, J, Desjobert, C, Lamant, L, Prósper, F, Felsher, D W, Cavaillé, J, Prats, H, Delsol, G, Giuriato, S, Meggetto, F, Prósper, F, Cavaillé, J

Publikováno v: Leukemia (08876924); Dec2011, Vol. 25 Issue 12, p1882-1890, 9p, 6 Graphs

ALK+ALCLs induce cutaneous, HMGB-1-dependent IL-8/CXCL8 production by keratinocytes through NF-κB activation.

Autor: Dejean E; Centre de Recherches en Cancérologie de Toulouse, Unité Mixte de Recherche, 1037 Inserm-Université Toulouse III, Toulouse, France., Foisseau M, Lagarrigue F, Lamant L, Prade N, Marfak A, Delsol G, Giuriato S, Gaits-Iacovoni F, Meggetto F

Publikováno v: Blood [Blood] 2012 May 17; Vol. 119 (20), pp. 4698-707. Date of Electronic Publication: 2012 Mar 06.

Development of a conditional bioluminescent transplant model for TPM3-ALK-induced tumorigenesis as a tool to validate ALK-dependent cancer targeted therapy.

Autor: Giuriato S; INSERM, U563, Centre de Physiopathologie de Toulouse Purpan, Toulouse, France. giuriato@toulouse.inserm.fr, Faumont N, Bousquet E, Foisseau M, Bibonne A, Moreau M, Al Saati T, Felsher DW, Delsol G, Meggetto F

Publikováno v: Cancer biology & therapy [Cancer Biol Ther] 2007 Aug; Vol. 6 (8), pp. 1318-23. Date of Electronic Publication: 2007 May 29.

ALK+ Anaplastic Large Cell Lymphoma (ALCL)-Derived Exosomes Carry ALK Signaling Proteins and Interact with Tumor Microenvironment.

Autor: Chioureas, Dimitrios¹ (AUTHOR) dimitrios.chioureas@ki.se, Beck, Janina¹ (AUTHOR) janina-beck@web.de, Baltatzis, George¹ (AUTHOR) gbaltatz@med.uoa.gr, Vardaki, Ioulia¹ (AUTHOR) ioulia.vardaki@ki.se, Fonseca, Pedro¹ (AUTHOR) pedro.fonseca@ki.se, Tsesmetzis, Nikolaos¹ (AUTHOR) nikolaos.tsesmetzis@ki.se, Vega, Francisco² (AUTHOR) fvega@mdanderson.org, Leventaki, Vasiliki³ (AUTHOR) vleventaki@mcw.edu, Eliopoulos, Aristides G.^4,5 (AUTHOR) eliopag@med.uoa.gr, Drakos, Elias⁶ (AUTHOR) drakil@uoc.gr, Rassidakis, George Z.^1,2,7 (AUTHOR) georgios.rassidakis@ki.se, Panaretakis, Theocharis^1,8 (AUTHOR)

Publikováno v: Cancers. Jun2022, Vol. 14 Issue 12, p2939-N.PAG. 13p.

De novo generation of the NPM-ALK fusion recapitulates the pleiotropic phenotypes of ALK+ ALCL pathogenesis and reveals the ROR2 receptor as target for tumor cells.

Autor: Babin, Loélia¹ (AUTHOR), Darchen, Alice¹ (AUTHOR), Robert, Elie² (AUTHOR), Aid, Zakia² (AUTHOR), Borry, Rosalie¹ (AUTHOR), Soudais, Claire³ (AUTHOR), Piganeau, Marion⁴ (AUTHOR), De Cian, Anne⁴ (AUTHOR), Giovannangeli, Carine⁴ (AUTHOR), Bawa, Olivia⁵ (AUTHOR), Rigaud, Charlotte⁶ (AUTHOR), Scoazec, Jean-Yves⁷ (AUTHOR), Couronné, Lucile⁸ (AUTHOR), Veleanu, Layla⁹ (AUTHOR), Cieslak, Agata⁹ (AUTHOR), Asnafi, Vahid⁹ (AUTHOR), Sibon, David⁹ (AUTHOR), Lamant, Laurence¹⁰ (AUTHOR), Meggetto, Fabienne¹⁰ (AUTHOR), Mercher, Thomas² (AUTHOR) thomas.mercher@inserm.fr

Publikováno v: Molecular Cancer. 3/4/2022, Vol. 21 Issue 1, p1-18. 18p.